[Immunologic prognostic parameters in infection by the human immunodeficiency virus]

R Máñez1, I Caragol, E Ribera

  • 1Servicio de Cuidados Intensivos, Hospital General Universitari de la Vall d'Hebron, Universidad Autónoma de Barcelona.

Medicina Clinica
|October 31, 1992
PubMed

Insights

Decreased CD4 lymphocytes and interferon-tau production in early-stage HIV infection predict disease progression. These immune markers can help identify patients at higher risk for developing AIDS.

Area of Science:

  • Immunology
  • Virology
  • Clinical Medicine

Background:

  • Human immunodeficiency virus (HIV) infection impacts the immune system.
  • Identifying prognostic markers is crucial for managing HIV disease progression.

Purpose of the Study:

  • To assess quantitative and functional immunologic parameters as predictors of HIV infection progression.
  • To evaluate immune markers for their prognostic value in HIV patients.

Main Methods:

  • Analyzed CD4/CD8 lymphocyte counts, CD4/CD8 ratio, IL-2 receptors, PHA response, and IFN-tau production in 85 HIV patients across different stages (II, III, IV) and 35 controls.
  • Utilized multivariate analysis to identify significant prognostic factors over a 30-month follow-up period.

Main Results:

  • Seventeen patients progressed to stage IV (AIDS) during the study.
  • A decrease in CD4 lymphocyte count in stage II and reduced IFN-tau production in stages II and III were significantly associated with progression to stage IV.

Conclusions:

  • Reduced interferon-tau (IFN-tau) production in stages II and III of HIV infection is a prognostic factor for progression to stage IV (AIDS).
  • A decline in CD4 lymphocyte count during stage II of HIV infection also indicates a higher risk of progressing to stage IV.
Abstract